Dithranol

Dithranol
Clinical data
AHFS/Drugs.com	Micromedex Detailed Consumer Information
Pregnancy; category	AU: B2; ;
Routes of; administration	topical
ATC code	D05AC01 (WHO) ;
Legal status
Legal status	UK: P (Pharmacy medicines);
Pharmacokinetic data
Bioavailability	0%, trace amounts metabolites
Protein binding	0%
Metabolism	absorbed and oxidised within the skin
Elimination half-life	n/a
Excretion	n/a
Identifiers
	IUPAC name 1,8-dihydroxy-9,10-dihydroanthracen-9-one;
CAS Number	1143-38-0 ;
PubChem CID	2202;
ChemSpider	2117 ;
UNII	U8CJK0JH5M;
KEGG	D00233 ;
ChEBI	CHEBI:37510 ;
ChEMBL	ChEMBL46469 ;
CompTox Dashboard (EPA)	DTXSID7024538 ;
ECHA InfoCard	100.013.216
Chemical and physical data
Formula	C14H10O3
Molar mass	226.231 g·mol−1
3D model (JSmol)	Interactive image;
Melting point	178 °C (352 °F)
	SMILES O=C2c1c(O)cccc1Cc3c2c(O)ccc3;
	InChI InChI=1S/C14H10O3/c15-10-5-1-3-8-7-9-4-2-6-11(16)13(9)14(17)12(8)10/h1-6,15-16H,7H2 ; Key:NUZWLKWWNNJHPT-UHFFFAOYSA-N ;
	(verify)

Dithranol (INN) or anthralin (USAN and former BAN) is a hydroxyanthrone, anthracene derivative, and is used in medications applied to the skin of people with psoriasis. It is available as creams, ointment or pastes in 0.1 to 2% strengths (Drithocreme, Dithrocream, Zithranol-RR, Micanol, Psorlin, Dritho-Scalp, Anthraforte, Anthranol and Anthrascalp). The terms dithranol and anthralin are sometimes used synonymously.